ISIS 678354
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISIS 678354, covering 2023-01-11 to 2023-01-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) [Phase 2]